HEPATITIS B REACTIVATION IN PATIENTS WITH NON HODGKIN LYMPHOMA CD20+ UNDERGOING CHEMOTHERAPY

被引：0
|
作者：
De Renzo, A. [1 ]
Masarone, M. [2 ]
Persico, M. [2 ]
Perna, F. [1 ]
Cuccurullo, R. [1 ]
Alfinito, F. [3 ]
Picardi, M. [1 ]
Del Vecchio, L. [1 ]
Luponio, S. [1 ]
Martinelli, V. [1 ]
Pane, F. [1 ]
机构：
[1] Univ Federicoll Naples, Naples, Italy
[2] Univ Naples 2, Naples, Italy
[3] It Hematol Div, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0285
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [31] Expression of B-cell intracellular signaling molecules in CD20+ classical Hodgkin's lymphoma
    Chiu, A
    Hyjek, E
    Chadburn, A
    Frizzera, G
    MODERN PATHOLOGY, 2005, 18 : 226A - 226A
  • [32] Expression of B-cell intracellular signaling molecules in CD20+ classical Hodgkin's lymphoma
    Chiu, A
    Hyjek, E
    Chadburn, A
    Frizzera, G
    LABORATORY INVESTIGATION, 2005, 85 : 226A - 226A
  • [33] LATE CARDIAC COMPLICATIONS HODGKIN AND NON HODGKIN LYMPHOMA PATIENTS UNDERGOING CHEMOTHERAPY AND RADIOTHERAPY
    Vullo, G.
    Fiorelli, S.
    Massaro, M.
    Bianchi, M. P.
    Pelliccia, S.
    Mariani, S.
    De Biase, L.
    Buonfrate, M.
    Maggiore, C.
    Brainovich, V.
    Marchioni, C.
    Tafuri, A.
    Osti, M. F.
    De Sanctis, V.
    HAEMATOLOGICA, 2021, 106 (10) : 150 - 150
  • [34] Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: A meta-analysis
    Dong, Hua-Jie
    Ni, Ling-Na
    Sheng, Gui-Feng
    Song, Hong-Lei
    Xu, Jian-Zhong
    Ling, Yang
    JOURNAL OF CLINICAL VIROLOGY, 2013, 57 (03) : 209 - 214
  • [35] Hepatitis B reactivation in patient with malignancy undergoing chemotherapy
    Sethia, Mohit
    Sood, Atul
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 741 - 741
  • [36] Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma
    Persico, M
    De Marino, F
    Russo, GD
    Severino, A
    Palmentieri, B
    Picardi, M
    Morante, A
    Rotoli, B
    Torella, R
    De Renzo, A
    BLOOD, 2002, 99 (02) : 724 - 725
  • [37] Research advances in reactivation of hepatitis virus after chemotherapy for non-Hodgkin's lymphoma-combined hepatitis B virus infection
    Shujun Ma
    国际感染病学(电子版), 2015, (03) : 75 - 80
  • [38] A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
    Hsu, Chiun
    Hsiung, Chao A.
    Su, Lh-Jen
    Hwang, Wei-Shou
    Wang, Ming-Chung
    Lin, Sheng-Fung
    Lin, Tseng-Hsi
    Hsiao, Hui-Hua
    Young, Ji-Hsiung
    Chang, Ming-Chih
    Liao, Yu-Min
    Li, Chi-Cheng
    Wu, Hung-Bo
    Tien, Hwei-Fang
    Chao, Tsu-Yi
    Hu, Tsang-Wu
    Cheng, Ann-Lii
    Chen, Pei-Jer
    HEPATOLOGY, 2008, 47 (03) : 844 - 853
  • [39] HEPATIC TOXICITY IN PATIENTS WITH NON HODGKIN'S LYMPHOMA (NHL) INFECTED WITH HEPATITIS C UNDERGOING CHEMOTHERAPY WITH RITUXIMAB
    Lepkov, S.
    Storogakov, G.
    Kovrigina, A.
    Tumyn, G.
    Kosura, S.
    Kolomeytsev, O.
    Zeynalova, P.
    Kondratieva, T.
    Melkova, K.
    Ettinger, O.
    Subortseva, I.
    Timofeeva, O.
    ANNALS OF ONCOLOGY, 2011, 22 : 226 - 226
  • [40] Treatment to Prevent Hepatitis B Virus Reactivation in Patients With Lymphoma Receiving Chemotherapy
    Baang, Jihoon
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (12): : 1269 - 1270
12345